Grapefruit derivative prevents
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Breast Cancer ~ Swine Flu ~ Lung Cancer ~ Heart attack ~ Pregnancy ~ All Health Topics
Home / Health News / 2009 / July 2009 / July 14, 2009
Grapefruit derivative prevents obesity
RSS / Print / Comments

Health News

Waist size, not BMI can foretell cardiovascular risk in children
A new study by researchers at the University of Georgia, the Menzies Research Institute in Hobart, Australia and the Murdoch Childrens Research Institute in Melbourne, Australia has found that waist circumference is a better indicator of a childs risk for cardiovascular disease and diabetes later in life, as compared to BMI. ANI

Internal body temperature regulates body clock
Fluctuations in internal body temperature regulate the bodys circadian rhythm, the 24-hour cycle that controls metabolism, sleep and other bodily functions, revealed UT Southwestern Medical Center researchers. ANI

Egyptian mummies discovery indicates 'cancer is man-made'
A study of ancient remains has found that cancer is a man-made disease fuelled by pollution and changes to diet and lifestyle. ANI

Grapefruit derivative prevents obesity

A new study on mice, conducted by University of Western Ontario researchers, has shown that grapefruit contains a substance thats a natural fat fighter.


Washington, July 14 : A new study on mice, conducted by University of Western Ontario researchers, has shown that grapefruit contains a substance that's a natural fat fighter.

Derived from citrus fruit, particularly grapefruit, the substance has shown it can reduce weight gain and fatty particles in the body, Murray Huff of UWO's Robarts Research Institute said.

The substance, a flavonoid - a bioactive molecule - called naringenin, shows promise as an inhibitor of conditions associated with type 2 diabetes and cardiovascular disease, he said.

In the study, one group of mice was fed a high-fat diet to induce the symptoms of metabolic syndrome. A second group was fed the exact same diet and treated with naringenin.

Naringenin corrected the elevations in triglyceride and cholesterol, prevented the development of insulin resistance and completely normalized glucose metabolism.

The researchers found it worked by genetically reprogramming the liver to burn up excess fat, rather than store it.

"Furthermore, the marked obesity that develops in these mice was completely prevented by naringenin," said Huff.

"What was unique about the study was that the effects were independent of caloric intake, meaning the mice ate exactly the same amount of food and the same amount of fat. There was no suppression of appetite or decreased food intake, which are often the basis of strategies to reduce weight gain and its metabolic consequences," Huff added.

This study investigated naringenin's preventative properties, but Huff is also investigating whether it can treat obesity and other existing metabolic problems.

The findings are published online in the journal Diabetes.

ANI

Link to this page

Suggested pages for your additional reading
AndhraNews.net on Facebook






© 2000-2017 AndhraNews.net. All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us